Clinical Trials Browser

Phase 2 × Blood Specimen Collection × Plasma cell × Clear all

NCT04150692 2022-01-24

Escalation of Daratumumab Frequency Following Biochemical Progression in Relapsed/Refractory Multiple Myeloma

Phase 2 Withdrawn

Multiple Myeloma

NCT02260414 2017-05-11

METRO B

Phase 2 Completed

LymphoidPlasma cell

Lymphoma, Multiple Myeloma